Diametric Capital, LP Ab Cellera Biologics Inc. Transaction History
Diametric Capital, LP
- $118 Million
- Q4 2024
A detailed history of Diametric Capital, LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Diametric Capital, LP holds 18,104 shares of ABCL stock, worth $59,200. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,104Holding current value
$59,200% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ABCL
# of Institutions
168Shares Held
120MCall Options Held
176KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY27.5MShares$90 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$40 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$34.7 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$25.9 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$24 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $932M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...